United States Healthcare Equipment & Supplies

Boston Scientific Corp (BSX)

Track

Over the past 90 days, Boston Scientific Corp insiders have executed eight buy transactions totaling approximately $9.84 million. Notably, CEO Michael F. Mahoney purchased over $9 million in shares in early August. These acquisitions follow the company's recent earnings report, which showed a 3.6% EPS beat, despite a 11.5% decline in stock price over the last quarter.
Ticker: BSX Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Boston Scientific Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 5 Aug 2026
Value US$4,305,294.87 | Price 478.72 | Shares 84,344 (-34.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-05 B Purchase
2.4
Habiger David C
Non-Executive Director
84,344 -34.8%
478.72
US$4,305,295 		84,344 -34.8% 478.72 US$4,305,295
2026-08-05 2026-08-04 B Purchase
2.4
Habiger David C
Non-Executive Director
71,272 -20.2%
251.28
US$2,021,812 		71,272 -20.2% 251.28 US$2,021,812
2026-08-05 2026-08-03 B Purchase
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
70,686 -47.7%
25.78
US$3,829,784 		70,686 -47.7% 25.78 US$3,829,784
2026-08-05 2026-08-03 B Purchase
2.4
Habiger David C
Non-Executive Director
1,000 +7.5%
48.07
US$100,000 		1,000 +7.5% 48.07 US$100,000
2026-08-03 2026-07-31 B Purchase
3.2
LUDWIG EDWARD J
Non-Executive Director
1,000 +19.7%
45.48
US$100,000 		1,000 +19.7% 45.48 US$100,000
2026-05-21 2026-05-20 B Purchase
1.9
Pegus Cheryl
Non-Executive Director
1,770 +inf%
56.49
US$99,987 		1,770 +inf% 56.49 US$99,987
2026-05-21 2026-05-20 B Purchase
2.4
Habiger David C
Non-Executive Director
2,250 +19.3%
55.92
US$125,819 		2,250 +19.3% 55.92 US$125,819
2026-05-21 2026-05-20 B Purchase
3.2
LUDWIG EDWARD J
Non-Executive Director
3,580 +16.4%
56.68
US$202,914 		3,580 +16.4% 56.68 US$202,914
2026-05-21 2026-05-19 B Purchase
2.4
Habiger David C
Non-Executive Director
2,200 +23.3%
56.95
US$125,279 		2,200 +23.3% 56.95 US$125,279
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
159,701 -10.2%
93.49
US$14,930,526 		159,701 -10.2% 93.49 US$14,930,526
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
1,200 -0.1%
94.06
US$112,868 		1,200 -0.1% 94.06 US$112,868
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
159,701 -10.2%
93.49
US$14,930,526 		159,701 -10.2% 93.49 US$14,930,526
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
1,200 -0.1%
94.06
US$112,868 		1,200 -0.1% 94.06 US$112,868
2026-02-02 2026-02-02 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
160,901
93.49
US$15,043,390 		160,901 93.49 US$15,043,390
2025-12-02 2025-12-01 PlS Planned sale
2.2
Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Officer
17,313 -42.3%
101.55
US$1,758,189 		17,313 -42.3% 101.55 US$1,758,189
2025-12-01 2025-12-01 PrS Proposed sale
2.2
ARTHUR C BUTCHER

Officer

Officer
17,313
101.55
US$1,758,188 		17,313 101.55 US$1,758,188
2025-11-06 2025-11-06 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
2,901
97.96
US$284,171 		2,901 97.96 US$284,171
2025-11-06 2025-11-06 PlS Planned sale
Zane Ellen M
Non-Executive Director
12,891 -34.8%
98.28
US$1,266,978 		12,891 -34.8% 98.28 US$1,266,978
2025-11-04 2025-11-03 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
29,472 -14.2%
99.14
US$2,921,895 		29,472 -14.2% 99.14 US$2,921,895
2025-11-04 2025-11-03 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
16,928 -7.5%
99.76
US$1,688,749 		16,928 -7.5% 99.76 US$1,688,749
2025-11-04 2025-11-03 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
3,600 -1.6%
100.75
US$362,693 		3,600 -1.6% 100.75 US$362,693
2025-11-03 2025-11-03 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
99.47
US$4,973,335 		50,000 99.47 US$4,973,335
2025-10-28 2025-10-28 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
2,901
102.24
US$296,592 		2,901 102.24 US$296,592
2025-10-28 2025-10-28 PlS Planned sale
Zane Ellen M
Non-Executive Director
2,901 -10.7%
102.24
US$296,599 		2,901 -10.7% 102.24 US$296,599
2025-10-28 2025-10-27 PlS Planned sale
Zane Ellen M
Non-Executive Director
9,990 -27.0%
101.13
US$1,010,301 		9,990 -27.0% 101.13 US$1,010,301
2025-10-27 2025-10-27 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
9,990
100.91
US$1,008,081 		9,990 100.91 US$1,008,081
2025-10-01 2025-10-01 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
98.47
US$4,923,325 		50,000 98.47 US$4,923,325
2025-10-01 2025-10-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
41,755 -19.0%
98.38
US$4,107,844 		41,755 -19.0% 98.38 US$4,107,844
2025-10-01 2025-10-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
8,245 -3.6%
98.91
US$815,482 		8,245 -3.6% 98.91 US$815,482
2025-09-03 2025-09-02 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
28,170 -13.6%
105.85
US$2,981,755 		28,170 -13.6% 105.85 US$2,981,755
2025-09-03 2025-09-02 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
21,830 -9.6%
104.89
US$2,289,661 		21,830 -9.6% 104.89 US$2,289,661
2025-09-02 2025-09-02 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
105.43
US$5,271,415 		50,000 105.43 US$5,271,415
2025-08-04 2025-08-01 PlS Planned sale
2.2
Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Officer
17,313 -42.3%
104.63
US$1,811,520 		17,313 -42.3% 104.63 US$1,811,520
2025-08-04 2025-08-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
50,000 -21.9%
104.63
US$5,231,670 		50,000 -21.9% 104.63 US$5,231,670
2025-08-01 2025-08-01 PrS Proposed sale
2.2
ARTHUR C BUTCHER

Officer

Officer
17,313
104.63
US$1,811,519 		17,313 104.63 US$1,811,519
2025-08-01 2025-08-01 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
104.63
US$5,231,665 		50,000 104.63 US$5,231,665
2025-07-30 2025-07-29 S Sale
2.7
FUJIMORI YOSHIAKI
Non-Executive Director
2,901 -58.2%
106.99
US$310,378 		2,901 -58.2% 106.99 US$310,378
2025-07-29 2025-07-29 PrS Proposed sale
2.7
YOSHIAKI FUJIMORI

Director

Non-Executive Director
2,901
106.99
US$310,378 		2,901 106.99 US$310,378
2025-07-28 2025-07-25 S Sale
3.2
LUDWIG EDWARD J
Non-Executive Director
4,000 -17.8%
106.03
US$424,120 		4,000 -17.8% 106.03 US$424,120
2025-07-25 2025-07-25 PrS Proposed sale
3.2
LUDWIG EDWARD J

Director

Non-Executive Director
4,000
107.46
US$429,840 		4,000 107.46 US$429,840
2025-07-02 2025-07-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
50,000 -21.9%
106.97
US$5,348,315 		50,000 -21.9% 106.97 US$5,348,315
2025-07-01 2025-07-01 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
106.97
US$5,348,310 		50,000 106.97 US$5,348,310
2025-06-04 2025-06-04 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
56,372
102.88
US$5,799,625 		56,372 102.88 US$5,799,625
2025-06-04 2025-06-04 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
56,372 -24.0%
102.88
US$5,799,630 		56,372 -24.0% 102.88 US$5,799,630
2025-06-03 2025-06-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
89,921 -5.7%
103.39
US$9,296,950 		89,921 -5.7% 103.39 US$9,296,950
2025-06-03 2025-06-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
74,522 -4.5%
104.05
US$7,754,186 		74,522 -4.5% 104.05 US$7,754,186
2025-06-02 2025-06-02 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
164,443
103.69
US$17,051,132 		164,443 103.69 US$17,051,132
2025-05-30 2025-05-29 S Sale
3.2
LUDWIG EDWARD J
Non-Executive Director
4,000 -15.1%
104.59
US$418,368 		4,000 -15.1% 104.59 US$418,368
2025-05-29 2025-05-29 PrS Proposed sale
3.2
LUDWIG EDWARD J

Director

Non-Executive Director
4,000
104.54
US$418,160 		4,000 104.54 US$418,160
2025-05-22 2025-05-21 PlS Planned sale
Brown Vance R

SVP, GC and Corp. Secretary

Officer
4,826 -13.3%
106.42
US$513,583 		4,826 -13.3% 106.42 US$513,583
2025-05-21 2025-05-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
106.42
US$513,583 		4,826 106.42 US$513,583
2025-05-06 2025-05-05 PlS Planned sale
3.7
Sorenson John Bradley

EVP, Global Operations

Officer
4,572 -19.6%
104.54
US$477,957 		4,572 -19.6% 104.54 US$477,957
2025-05-05 2025-05-05 PrS Proposed sale
3.7
JOHN B SORENSON

Officer

Officer
4,572
104.54
US$477,957 		4,572 104.54 US$477,957
2025-05-05 2025-05-01 PlS Planned sale
2.2
Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Officer
17,314 -43.8%
102.06
US$1,766,982 		17,314 -43.8% 102.06 US$1,766,982
2025-05-05 2025-05-01 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
91,282 -5.6%
102.13
US$9,322,266 		91,282 -5.6% 102.13 US$9,322,266
2025-05-05 2025-05-01 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
73,161 -4.3%
102.92
US$7,529,708 		73,161 -4.3% 102.92 US$7,529,708
2025-05-01 2025-05-01 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
164,443
102.48
US$16,851,966 		164,443 102.48 US$16,851,966
2025-05-01 2025-05-01 PrS Proposed sale
2.2
ARTHUR C BUTCHER

Officer

Officer
17,314
102.06
US$1,766,981 		17,314 102.06 US$1,766,981
2025-04-22 2025-04-21 PlS Planned sale
Brown Vance R

SVP, GC and Corp. Secretary

Officer
4,826 -11.8%
95.09
US$458,904 		4,826 -11.8% 95.09 US$458,904
2025-04-21 2025-04-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
95.09
US$458,904 		4,826 95.09 US$458,904
2025-04-02 2025-04-01 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
164,442 -9.3%
100.01
US$16,445,072 		164,442 -9.3% 100.01 US$16,445,072
2025-04-01 2025-04-01 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
164,442
100.01
US$16,445,068 		164,442 100.01 US$16,445,068
2025-03-24 2025-03-21 PlS Planned sale
Brown Vance R

SVP, GC and Corp. Secretary

Officer
4,826 -10.5%
100.85
US$486,702 		4,826 -10.5% 100.85 US$486,702
2025-03-21 2025-03-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
100.85
US$486,702 		4,826 100.85 US$486,702
2025-03-05 2025-03-04 PlS Planned sale
Woodworth Emily

SVP, Global Controller and CAO

Officer
482 -52.7%
104.63
US$50,432 		482 -52.7% 104.63 US$50,432
2025-03-05 2025-03-03 PlS Planned sale
Woodworth Emily

SVP, Global Controller and CAO

Officer
7,149 -88.7%
104.97
US$750,465 		7,149 -88.7% 104.97 US$750,465
2025-03-03 2025-02-28 PlS Planned sale
Woodworth Emily

SVP, Global Controller and CAO

Officer
9,887 -85.8%
101.13
US$999,872 		9,887 -85.8% 101.13 US$999,872
2025-02-25 2025-02-25 PrS Proposed sale
JEFFREY B MIRVISS

Officer

Officer
2,688
104.00
US$279,552 		2,688 104.00 US$279,552
2025-02-25 2025-02-25 PlS Planned sale
Mirviss Jeffrey B.

EVP&Pres, Periph Intervent

Officer
2,688 -9.4%
104.00
US$279,552 		2,688 -9.4% 104.00 US$279,552
2025-02-25 2025-02-24 PlS Planned sale
Mirviss Jeffrey B.

EVP&Pres, Periph Intervent

Officer
4,675 -14.1%
104.25
US$487,369 		4,675 -14.1% 104.25 US$487,369
2025-02-24 2025-02-24 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
13,586
104.23
US$1,416,088 		13,586 104.23 US$1,416,088
2025-02-24 2025-02-24 PrS Proposed sale
JEFFREY B MIRVISS

Officer

Officer
4,675
104.25
US$487,369 		4,675 104.25 US$487,369
2025-02-24 2025-02-24 PlS Planned sale
Zane Ellen M
Non-Executive Director
13,586 -28.0%
104.23
US$1,416,134 		13,586 -28.0% 104.23 US$1,416,134
2025-02-21 2025-02-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
104.64
US$504,993 		4,826 104.64 US$504,993
2025-02-21 2025-02-21 PlS Planned sale
Brown Vance R

SVP, GC and Corp. Secretary

Officer
4,826 -9.5%
104.64
US$504,993 		4,826 -9.5% 104.64 US$504,993
Explore more

More insider trading research around Boston Scientific Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America
Insider trades in S&P 500